Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas

Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro

Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors

Recombinant Newcastle disease virus immunotherapy drives oncolytic effects and durable systemic antitumor immunity

A bibliometric review of oncolytic virus research as a novel approach for cancer therapy

MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells

Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus

The oncolytic Newcastle disease virus as an effective immunotherapeutic strategy against glioblastoma